agilon health Sets Date to Report Q1 2026 Earnings
agilon health, a healthcare technology company, announced it will release its financial results for the first quarter of 2026 after market close on Wednesday, May 6, 2026. The company will also host a conference call on the same day at 4:30 PM Eastern Time to discuss the results. This report will provide insight into the company's progress in empowering physicians and improving community healthcare through its technology-enabled solutions.
agilon health Sets Date to Report First Quarter 2026 Financial Results
agilon health, a healthcare technology company, announced it will release its first quarter 2026 financial results after market close on May 6, 2026. The company will host a conference call on the same day at 4:30 p.m. ET to discuss the results. This report is expected to provide key insights into the company's growth and the broader shift towards value-based care in the healthcare industry.
agilon health Sets Date to Report First Quarter 2026 Financial Results
agilon health (NYSE: AGL) announced it will release its first-quarter 2026 financial results after market close on Wednesday, May 6, 2026. The company will host a conference call at 4:30 p.m. ET to discuss these results. Interested parties can access the conference call via a dial-in number or a simultaneous webcast on agilon health’s Investor Relations website.
agilon health Sets Date to Report First Quarter 2026 Financial Results
agilon health (NYSE: AGL) announced it will release its first-quarter 2026 financial results after market close on Wednesday, May 6, 2026. The company will host a conference call at 4:30 p.m. ET to discuss these results, which will also be accessible via a webcast on its Investor Relations website. agilon health is a partner for physicians, empowering them to transition to a value-based Total Care Model for senior patients.
Agilon Health (AGL) Soars 25% in Intraday Surge: What’s Driving This Volatile Rally?
Agilon Health (AGL) experienced a significant 25% intraday surge, reaching $13.425, primarily driven by a broader sector optimism following OSI Systems' $40 million medical device contract, rather than specific news from Agilon itself. This rally was marked by high options trading volume and increased volatility, with the stock entering an overbought condition. While the surge appears to be a sector-wide wave benefiting healthcare equipment stocks, the article cautions about Agilon's extreme volatility and speculative activity, suggesting a need for investors to act quickly due to the fast-moving market.
agilon health (AGL) CAO gets 10,000 RSUs, 266 shares withheld for taxes
agilon health's Chief Accounting Officer, Timothy Gertsch, was granted 10,000 restricted stock units (RSUs) which vest in three equal installments starting April 1, 2026. Concurrently, 266 shares were withheld by the company to cover income tax obligations related to the RSU net settlement, not as an open-market sale. Following these transactions and accounting for a recent 1-for-25 reverse stock split, Gertsch beneficially owns 14,324 shares of Common Stock.
agilon health (AGL) CTO receives 28,000-share RSU grant and tax withholding entry
agilon health's CTO, Venkatachaliah Girish, reported a routine equity compensation of 28,000 Restricted Stock Units (RSUs) on April 1, 2026, which vest in three equal annual installments subject to continued employment. Concurrently, 480 shares were withheld at $9.75 each to cover income tax obligations, explicitly not representing a sale. Following these transactions, his beneficial ownership increased to 38,662 shares, a figure that accounts for a 1-for-25 reverse stock split effective March 30, 2026.
agilon health (AGL) CMO granted 70,000 RSUs, holdings now 123,525 shares
agilon health's Chief Markets Officer, Benjamin Shaker, was granted 70,000 restricted stock units (RSUs) and had 1,664 shares withheld for tax obligations. This transaction increased his total holdings to 123,525 shares, reflecting a recent 1-for-25 reverse stock split. The RSUs will vest in three equal installments annually, contingent on continued employment.
agilon health (AGL) CFO receives 75,000 RSUs after reverse stock split
agilon health's CFO, Jeffrey A. Schwaneke, was granted 75,000 restricted stock units (RSUs) on April 1, 2026, which will vest in three equal annual installments conditioned on his continued employment. Concurrently, 1,662 shares were withheld for income tax obligations related to RSU net settlement, not an open-market sale. These transactions occurred after the company's 1-for-25 reverse stock split on March 30, 2026, and Schwaneke now directly beneficially owns 140,342 shares, including RSUs.
[Form 4] agilon health, inc. Insider Trading Activity
This article details a Form 4 filing for agilon health, inc. (AGL) revelating insider trading activity by Chief Legal Officer Denise Zamore. The filing reports a routine grant of 50,000 shares of Common Stock as equity compensation and the withholding of 1,024 shares to cover tax obligations. These transactions reflect a post-reverse stock split adjustment and clarify that the share withholding was not an open-market sale.
agilon health inc stock: Reverse Split Sparks Analyst Optimism
Agilon Health's recent 1-for-25 reverse stock split has led to increased analyst optimism and raised price targets, positioning the company as a potential investment in the value-based healthcare sector. Despite prior share price volatility and ongoing losses, the move is seen by some as a strategic reset to attract institutional investors and capitalize on the growing Medicare Advantage market. The company's model focuses on empowering primary care physicians with technology to improve patient outcomes and manage care costs.
agilon health inc stock: Reverse Split Sparks Analyst Optimism
Agilon Health's recent 1-for-25 reverse stock split has sparked renewed analyst optimism, with firms like Benchmark raising price targets. This move aims to increase the per-share price, making the stock more attractive to institutional investors and reinforcing the company's strategic focus on transforming primary care through value-based models. While revenue growth remains strong, profitability is still a challenge due to investments, prompting investors to monitor medical cost trends and member growth for future catalysts.
Why Agilon Health (AGL) is doing a 1-for-25 reverse split to stay NYSE-compliant
Agilon Health (AGL) is implementing a 1-for-25 reverse stock split to boost its share price and maintain compliance with the New York Stock Exchange's listing requirements. The reverse split is effective before markets open on April 5, 2026. Fractional shares will be rounded up to the nearest whole share.
Benchmark raises agilon health stock price target on reverse split
Benchmark has increased its price target for agilon health Inc (NYSE:AGL) to $13.00 from $1.50, based on a 1:25 reverse stock split and adjustments to its financial model. Despite the new target, which suggests potential upside from the current trading price of $9.75, shares have dropped over 90% in the past year. The firm also adjusted its EBITDA estimates, reflecting both positive alignment with company guidance for 2026 and a reduced outlook for 2027 due to Medicare Advantage rate changes.
Agilon Health (NYSE:AGL) Stock Price Expected to Rise, Benchmark Analyst Says
Benchmark raised its price target for Agilon Health (NYSE: AGL) from $1.50 to $13.00, maintaining a "buy" rating, which suggests a 25% upside despite mixed analyst coverage. The company recently missed its quarterly EPS estimates, reporting -$0.46 against an expected -$0.27, although revenue exceeded expectations at $1.57 billion. Agilon Health currently trades around $10.40, has a market cap of approximately $172.6 million, and negative margins.
Agilon Health (NYSE:AGL) Shares Up 9.3% - Should You Buy?
Agilon Health (NYSE:AGL) saw its shares rise by 9.3% on Wednesday, although on lighter trading volume. The company reported a significant earnings per share miss in Q4 despite revenue beating estimates, and analysts maintain a "Hold" rating with varied price targets. Despite weak profitability, institutional investors have substantially increased their stakes in AGL.
Agilon Health Enacts 1-for-25 Reverse Stock Split
Agilon Health (AGL) successfully implemented a 1-for-25 reverse stock split on March 30, 2026, following shareholder approval. This action, effective March 31, 2026, on the NYSE, aims to increase the per-share trading price and maintain listing standards, with cash being paid for fractional shares. Despite a Sell rating from analysts and a Neutral score from TipRanks' AI due to financial performance and technical trends, the company continues to focus on value-based care in the healthcare services industry for senior patients.
AGILON HEALTH STOCKHOLDER ALERT: Kaskela Law Firm Announces Stockholder Investigation of Agilon Health, Inc.and Encourages Long-Term AGL Stockholders to Contact the Firm
Kaskela Law Firm has initiated an investigation into Agilon Health, Inc. (NYSE: AGL) following a securities fraud complaint alleging that Agilon and its executives made misleading statements about the company's medical costs, causing a significant stock price decline. The firm is encouraging long-term Agilon shareholders who purchased shares before May 1, 2023, to contact them to discuss their legal rights. The stock value reportedly dropped by approximately 85% during the relevant period.
Agilon Health Enacts 1-for-25 Reverse Stock Split
Agilon Health has completed a 1-for-25 reverse stock split, effective March 30, 2026, consolidating existing shares and adjusting equity plans. The stock will begin trading on a split-adjusted basis on the NYSE from March 31, 2026, under the same ticker, AGL. Spark, TipRanks' AI Analyst, rates AGL as Neutral due to weak financial performance and bearish technical trends, despite management's turnaround plans.
1-for-25 reverse split reshapes agilon health (NYSE: AGL) share count
agilon health has implemented a 1-for-25 reverse stock split, effective March 30, 2026, at 4:36 p.m. Eastern Time. This action reduces the number of outstanding shares without altering total equity or par value, with fractional shares being compensated in cash. Trading will commence on a split-adjusted basis on the NYSE under the existing AGL symbol starting March 31, 2026.
Why agilon health (AGL) Is Doing a 1-for-25 Reverse Split to Stay NYSE-Compliant
agilon health (AGL) is implementing a 1-for-25 reverse stock split, effective March 30, 2026, to regain compliance with the NYSE's minimum bid price requirement. The split will combine 25 outstanding shares into one, reducing the total outstanding shares to approximately 16.6 million and is intended to improve stock marketability and investor interest. The company partners with physician groups and health systems to support value-based care for senior patients.
Why Agilon Health (AGL) is doing a 1-for-25 reverse split to stay NYSE-compliant
Agilon Health (AGL) is implementing a 1-for-25 reverse stock split to regain compliance with the New York Stock Exchange's minimum share price requirement. The company's stock has faced significant declines over the past year, falling below the $1 threshold. The reverse split aims to increase the stock price, making it eligible to remain listed on the NYSE.
Agilon Health outlines $5.5B revenue and breakeven adjusted EBITDA for 2026 amid transformation and disciplined contracting
Agilon Health projects $5.5 billion in revenue and breakeven adjusted EBITDA by 2026. This outlook comes as the company undergoes a significant transformation, including a reduction in its operating footprint. The strategy emphasizes disciplined contracting and aims for sustainable growth and improved financial health.
Why agilon health (AGL) Is Doing a 1-for-25 Reverse Split to Stay NYSE-Compliant
Agilon Health (AGL) is conducting a 1-for-25 reverse stock split to regain compliance with the New York Stock Exchange's minimum bid price requirement. The split, effective March 30, 2026, aims to increase the share price above $1.00 and potentially improve the stock's marketability and liquidity. Post-split, the number of outstanding shares will reduce to approximately 16.6 million, with adjustments for fractional shares and equity awards.
5 Penny Stocks with Potential to Rise 1000 Percent
This article highlights agilon health, inc. (NYSE:AGL) as one of five penny stocks with significant upside potential. agilon health recently announced a 1-for-25 reverse stock split, effective March 30, 2026, to meet NYSE minimum bid price requirements and improve stock marketability. The company partners with physician groups to support a value-based care model for senior patients.
agilon health inc stock faces pressure from 7.6% drop amid cost concerns and looming 1-for-10 reverse split
Agilon Health Inc. shares recently dropped 7.6% due to increasing cost pressures in its Medicare-centric model, alongside the announcement of a 1-for-10 reverse stock split effective March 31, 2026, aimed at improving liquidity. The company faces investor skepticism as year-to-date losses reach 11.8%, with shares trading near 52-week lows, compounded by ongoing lawsuits alleging misleading 2025 financial guidance. This situation highlights the challenges of balancing platform scalability with capitated risk execution in the volatile healthcare sector.
Bernstein Downgrades agilon health (AGL)
Bernstein has downgraded agilon health (AGL) stock. The article mentions that Bernstein is the only firm to have a "Sell" rating on AGL. The stock currently has an average rating of "Hold" and a consensus price target of $7.50.
agilon health inc stock plunges amid cash burn concerns and Medicare risks in 2026
Agilon Health Inc.'s stock has fallen sharply by over 30% in March 2026 due to investor concerns about cash burn and projected sales declines, impacting its value-based care model for seniors. Analysts point to negative free cash flow margins and increasing Medicare Advantage scrutiny as key issues, making it a high-risk, high-reward investment for DACH investors. The company's future hinges on its ability to improve cost efficiencies and adapt to regulatory changes.
agilon health inc stock plunges amid cash burn concerns and Medicare risks in 2026
Agilon Health Inc. (US00857U1079) stock has sharply declined in March 2026 due to investor concerns over cash burn, projected sales drops, and Medicare policy risks. The company, which operates on a value-based care model for seniors, saw shares fall over 30% in March and 37% year-to-date, trading around $0.43. Analysts highlight negative free cash flow, efficiency erosion, and increasing scrutiny of value-based care models as key factors driving skepticism and urging caution for investors, especially those in DACH portfolios.
If You Invested $1,000 in Agilon Health Inc (AGL)
This article analyzes the historical performance of a $1,000 investment in Agilon Health Inc (AGL). It shows that such an investment would have significantly decreased in value over one, five, and ten years, underperforming the S&P 500. The article also provides an overview of Agilon Health Inc, detailing its business model focused on value-based care for senior patients.
AGL SEC Filings - Agilon Health Inc 10-K, 10-Q, 8-K Forms
This page provides access to Agilon Health Inc. (AGL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider trading forms. It details how the company operates, its value-based care model, and governance. The platform also offers AI-powered tools to summarize key points from these regulatory disclosures.
Agilon Health Announces 1-for-25 Reverse Stock Split
Agilon Health (AGL) announced a 1-for-25 reverse stock split, effective March 30, 2026, to increase its share price above the NYSE’s minimum requirement and improve liquidity. This decision follows shareholder approval and aims to preserve the company's listing. Analysts currently rate AGL as a Hold with a $0.68 price target, while TipRanks' AI Analyst assigns a Neutral rating due to weak financial performance and high risk despite some positive outlook from the latest earnings call.
Agilon Health, Inc. (NYSE:AGL) Given Average Recommendation of "Hold" by Analysts
Agilon Health, Inc. (NYSE: AGL) has received a consensus "Hold" rating from sixteen analysts, with an average 12-month price target of $2.18. The company recently announced a 1-for-25 reverse stock split effective March 31st and reported a Q4 EPS miss, though revenue beat estimates. Shares plunged by 18.7% to $0.48, and analysts project a negative EPS for the current fiscal year.
Reverse split at agilon health (NYSE: AGL) targets NYSE compliance
agilon health (NYSE: AGL) announced a 1-for-25 reverse stock split, effective March 30, 2026, with trading on a split-adjusted basis starting March 31, 2026. This action, approved by stockholders, aims to raise the company's share price above $1.00 to meet NYSE listing requirements and improve marketability. Approximately 16.6 million shares will be outstanding after the split, with fractional shares being cashed out.
agilon health announces 1-for-25 reverse stock split By Investing.com
agilon health (NYSE: AGL) has announced a 1-for-25 reverse stock split, effective March 30, 2026, to meet NYSE's minimum bid price requirement. The company's stock currently trades at $0.59, and the split is expected to increase its price above $1.00 per share. As a result, approximately 16.6 million shares will be outstanding, with fractional shares being paid in cash.
Agilon Health announces 1-for-25 reverse stock split
Agilon Health has announced a 1-for-25 reverse stock split of its common stock. This corporate action is typically undertaken to increase the per-share trading price and reduce the number of outstanding shares. The article provides a factual report of this announcement.
agilon health announces 1-for-25 reverse stock split By Investing.com
agilon health, inc. (NYSE:AGL) announced a 1-for-25 reverse stock split to become effective on March 30, 2026, with trading on a split-adjusted basis starting March 31, 2026. This action is intended to raise the company's stock price above the NYSE's $1.00 minimum bid price requirement, as its shares currently trade at $0.59. Following the split, approximately 16.6 million shares will be outstanding, and fractional shares will be compensated with cash.
Agilon Health Announces 1-for-25 Reverse Stock Split
Agilon Health (AGL) announced a 1-for-25 reverse stock split, effective March 30, 2026, with trading under the new ratio starting March 31. This move, approved by shareholders, aims to raise the share price above the NYSE's $1.00 minimum to maintain its listing and reduce outstanding shares to about 16.6 million. An analyst has a hold rating on AGL with a $0.68 price target, while TipRanks’ AI Analyst, Spark, rates it as Neutral due to weak financial performance and market risks, despite improved 2026 EBITDA guidance.
agilon health Announces Reverse Stock Split
agilon health, inc. announced it will implement a 1-for-25 reverse stock split of its common stock, effective March 30, 2026. The split aims to increase the stock price above $1.00 to meet NYSE listing requirements, improve marketability, and attract more investors. Fractional shares will be cashed out, and proportional adjustments will be made to equity incentive plans.
Short Interest in Agilon Health, Inc. (NYSE:AGL) Grows By 20.5%
Short interest in Agilon Health (NYSE:AGL) increased by 20.5% in February, reaching 24,591,484 shares, which represents 6.1% of the company's shares sold short and a short-interest ratio of 3.3 days. The company recently reported an EPS miss but revenue beat expectations, leading to mixed analyst ratings with an average "Hold" rating and a target price of $2.18. Agilon Health, a healthcare company focused on value-based care for Medicare beneficiaries, has seen a debt-to-equity ratio of 0.12 and a market capitalization of $248.51 million.
AGL - Agilon Health Inc Latest Stock News & Market Updates
This page provides the latest news and analysis for Agilon Health (AGL), focusing on updates relevant to investors and traders. It aggregates company-specific news including financial results, leadership changes, investor conference participation, and research related to its value-based healthcare model for senior patients. Key announcements include Q1 2021 financial results and details of its initial public offering.
Capital International Investors Has $8.48 Million Stake in Agilon Health, Inc. $AGL
Capital International Investors has reduced its stake in Agilon Health by 16.8%, now holding 8.23 million shares valued at $8.48 million. Despite this, other institutions like CenterBook Partners significantly increased their holdings. Agilon Health currently holds a consensus "Hold" rating from analysts with a target price of $2.18, trading around $0.60 per share after missing recent EPS estimates.
Agilon Health, Inc. $AGL Holdings Cut by Capital World Investors
Capital World Investors significantly reduced its stake in Agilon Health (NYSE: AGL) by 81.6% in Q3, selling over 37 million shares. Agilon's recent earnings report showed a miss on EPS expectations but a beat on revenue, with its shares opening down. Despite some other institutional investors increasing their positions, analysts generally maintain a "Hold" rating with an average price target of $2.18.
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of agilon health, inc. (NYSE: AGL) breached their fiduciary duties to shareholders. The investigation seeks to determine if long-term shareholders are entitled to corporate governance reforms, the return of funds, or other relief. This announcement follows a negative market reaction to the news, as AGL's stock declined 5.10% on the day of publication.
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of agilon health, inc. (NYSE: AGL) breached their fiduciary duties to shareholders. The firm encourages current long-term agilon shareholders to contact them to discuss potential legal rights and options, including corporate governance reforms or the return of funds to the company. Shareholder involvement is highlighted as crucial for improving company policies and enhancing shareholder value.
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of agilon health, inc. (NYSE: AGL) breached their fiduciary duties to shareholders. The firm encourages current long-term shareholders to contact them to discuss potential corporate governance reforms, recovery of funds, or other benefits. This investigation aims to enhance shareholder value through improved company policies and oversight.
Agilon Health Shares Fall After 2026 Cost Trend Projection - News and Statistics
Agilon Health's stock declined following a company presentation at a financial conference where it projected an increase in cost trends for 2026, raising investor concerns about future profitability. Despite outlining long-term goals like achieving free cash flow break-even by 2027 and anticipating benefits from contract improvements, the near-term cost outlook negatively impacted market sentiment. The company's shares are known for volatility and have been trading significantly below their previous year's high, with an initial public offering investment now worth considerably less.
Why agilon health (AGL) Stock Is Down Today
Agilon Health (AGL) stock dropped 13.5% after a disheartening February jobs report indicated an unexpected contraction in employment, particularly impacting the healthcare sector with 28,000 job losses. This negative data has fueled investor concerns about a potential economic slowdown, which could subsequently reduce healthcare spending and demand. This downturn follows a recent 23.1% stock gain due to Chief Markets Officer Benjamin Shaker's significant purchase of 500,000 shares, signaling insider confidence in the company.
Kuehn Law Encourages Investors of Agilon Health, Inc. to Contact Law Firm
Kuehn Law, PLLC is investigating whether officers and directors of Agilon Health, Inc. (NYSE: AGL) breached their fiduciary duties to shareholders. A federal securities lawsuit alleges that the company's 2025 guidance was recklessly issued and that the positive financial impact from strategic actions was materially overstated. Shareholders who purchased AGL prior to February 26, 2025, are encouraged to contact the law firm.
agilon health (AGL) Shares Skyrocket, What You Need To Know
Shares of agilon health (AGL) surged by 23.1% after its Chief Markets Officer purchased 500,000 shares, signaling strong executive confidence in the company's future. The market reacted positively to this insider buying, interpreting it as a belief that the stock is undervalued. Despite this recent jump, AGL remains significantly below its 52-week high, and investors who bought at the IPO have seen a substantial decrease in their investment value.
